Creative Planning Boosts Stake in Xylem Inc. (NYSE:XYL)

Creative Planning grew its holdings in Xylem Inc. (NYSE:XYL) by 9.8% in the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 28,515 shares of the industrial products company’s stock after buying an additional 2,536 shares during the period. Creative Planning’s holdings in Xylem were worth $3,850,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors have also modified their holdings of XYL. Swedbank AB lifted its position in Xylem by 1.0% in the second quarter. Swedbank AB now owns 2,436,974 shares of the industrial products company’s stock valued at $330,527,000 after acquiring an additional 25,308 shares during the last quarter. Mirova US LLC raised its stake in Xylem by 2.0% in the 2nd quarter. Mirova US LLC now owns 1,876,618 shares of the industrial products company’s stock valued at $254,526,000 after purchasing an additional 36,013 shares during the last quarter. DekaBank Deutsche Girozentrale boosted its holdings in shares of Xylem by 2.2% during the second quarter. DekaBank Deutsche Girozentrale now owns 1,665,090 shares of the industrial products company’s stock worth $227,364,000 after purchasing an additional 36,601 shares during the last quarter. Dimensional Fund Advisors LP lifted its holdings in shares of Xylem by 8.3% during the 2nd quarter. Dimensional Fund Advisors LP now owns 1,474,033 shares of the industrial products company’s stock worth $199,930,000 after acquiring an additional 113,571 shares during the period. Finally, Sei Investments Co. boosted its holdings in shares of Xylem by 3.1% in the 2nd quarter. Sei Investments Co. now owns 1,045,023 shares of the industrial products company’s stock valued at $141,736,000 after purchasing an additional 31,709 shares during the last quarter. Hedge funds and other institutional investors own 87.96% of the company’s stock.

Xylem Stock Performance

Shares of XYL stock opened at $130.40 on Friday. The firm has a market capitalization of $31.67 billion, a price-to-earnings ratio of 41.27, a PEG ratio of 2.31 and a beta of 1.04. The business’s 50-day moving average price is $133.67 and its 200-day moving average price is $135.19. The company has a current ratio of 1.85, a quick ratio of 1.33 and a debt-to-equity ratio of 0.19. Xylem Inc. has a 12 month low of $87.59 and a 12 month high of $146.08.

Xylem (NYSE:XYL) last posted its earnings results on Tuesday, July 30th. The industrial products company reported $1.09 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.05 by $0.04. The firm had revenue of $2.17 billion during the quarter, compared to analyst estimates of $2.14 billion. Xylem had a net margin of 9.11% and a return on equity of 9.48%. The business’s revenue was up 26.0% compared to the same quarter last year. During the same quarter in the prior year, the business posted $0.98 EPS. Equities research analysts forecast that Xylem Inc. will post 4.26 EPS for the current year.

Xylem Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Thursday, September 26th. Stockholders of record on Thursday, August 29th were issued a dividend of $0.36 per share. This represents a $1.44 annualized dividend and a dividend yield of 1.10%. The ex-dividend date of this dividend was Thursday, August 29th. Xylem’s payout ratio is 45.57%.

Analysts Set New Price Targets

XYL has been the subject of a number of recent research reports. Stifel Nicolaus increased their target price on Xylem from $170.00 to $172.00 and gave the company a “buy” rating in a research note on Wednesday, July 31st. Royal Bank of Canada boosted their price objective on Xylem from $160.00 to $163.00 and gave the company an “outperform” rating in a research report on Wednesday, July 31st. TD Cowen restated a “hold” rating and issued a $138.00 target price on shares of Xylem in a research report on Tuesday, September 3rd. Robert W. Baird upped their price objective on Xylem from $155.00 to $170.00 and gave the company an “outperform” rating in a report on Wednesday, July 31st. Finally, UBS Group assumed coverage on Xylem in a research report on Tuesday, August 13th. They set a “buy” rating and a $165.00 price objective for the company. Four equities research analysts have rated the stock with a hold rating and nine have issued a buy rating to the company’s stock. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $149.67.

Xylem Company Profile

Xylem Inc, together with its subsidiaries, engages in the design, manufacture, and servicing of engineered products and solutions worldwide. It operates through four segments: Water Infrastructure, Applied Water, Measurement & Control Solutions, and Integrated Solutions and Services. The Water Infrastructure segment offers products, including water, storm water, and wastewater pumps; controls and systems; filtration, disinfection, and biological treatment equipment; and mobile dewatering equipment and rental services under the ADI, Flygt, Godwin, Sanitaire, Magneto, Neptune Benson, Ionpure, Leopold, Wedeco, and Xylem Vue brands.